Pravesh Vishwakarma

Featured in: Favicon

radcliffecardiology.com Favicon

onlinelibrary.wiley.com

Articles

AHA 24 Late-Breaking Discussion: SUMMIT: Tirzepatide in Patients with HFpEF and Obesity

Nov 18, 2024 | radcliffecvrm.com | Harriette Van Spall |Milton Packer |Rishi Sethi |Pravesh Vishwakarma

AHA Conference 2024 — New insights into the SUMMIT trial, investigating tirzepatide in patients with heart failure with preserved ejection fraction (HFpEF) and obesity.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →